Search research articles
Contact Us
Filters
Showing results (11-20 of 53) with videos related to
Page
of 6
Sort By:
Plos One
|
April 5, 2019
Real-world effectiveness and safety of sofosbuvir/velpatasvir and ledipasvir/sofosbuvir hepatitis C treatment in a single centre in Germany
Peter Buggisch, Karsten Wursthorn, Albrecht Stoehr, et al.
British Journal of Haematology
|
January 17, 2007
Adoptive transfer of syngeneic T cells in HIV-1 discordant twins indicates rapid regulation of T-cell homeostasis
Christian Hoffmann, Hans-Juergen Stellbrink, Thomas Dielschneider, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
February 16, 2021
Glecaprevir/pibrentasvir is safe and effective in hepatitis C patients with cirrhosis: Real-world data from the German Hepatitis C-Registry
Heiner Wedemeyer, Peter Erren, Uwe Naumann, et al.
Zeitschrift Fur Gastroenterologie
|
April 22, 2026
[Hyperlipasemia following therapy with direct antiviral drugs in patients with chronic hepatitis C virus infection - data from the German Hepatitis C Registry (DHC-R)]
Bernd Heinrich, Peter Buggisch, Gerlinde Teuber, et al.
Deutsches Arzteblatt International
|
March 16, 2011
HIV and cancer in Germany
Manfred Hensel, Armin Goetzenich, Thomas Lutz, et al.
AIDS Care
|
February 29, 2020
Physical and mental health in HIV-infected patients with virological success and long-term exposure to antiretroviral therapy
Michael Sabranski, Gesa Erdbeer, Ina Sonntag, et al.
Zeitschrift Fur Gastroenterologie
|
July 15, 2022
Real-world experience for the outcomes and costs of treating hepatitis C patients: Results from the German Hepatitis C-Registry (DHC-R)
Kathrin Krüger, Siegbert Rossol, Christian Krauth, et al.
Journal of Viral Hepatitis
|
August 2, 2021
The changing characteristics of patients infected with chronic hepatitis C virus from 2014 to 2019: Real-world data from the German Hepatitis C-Registry (DHC-R)
Dietrich Hüppe, Albrecht Stoehr, Peter Buggisch, et al.
Plos One
|
June 16, 2022
Prognostic impact of steatosis in the clinical course of chronic HCV infection-Results from the German Hepatitis C-Registry
Monika Rau, Peter Buggisch, Stefan Mauss, et al.
Viruses
|
July 27, 2022
Real-World Safety, Effectiveness, and Patient-Reported Outcomes in Patients with Chronic Hepatitis C Virus Infection Treated with Glecaprevir/Pibrentasvir: Updated Data from the German Hepatitis C-Registry (DHC-R)
Markus Cornberg, Albrecht Stoehr, Uwe Naumann, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 53) with videos related to
Sort By:
Page
of 6
Plos One
|
April 5, 2019
Real-world effectiveness and safety of sofosbuvir/velpatasvir and ledipasvir/sofosbuvir hepatitis C treatment in a single centre in Germany
Peter Buggisch, Karsten Wursthorn, Albrecht Stoehr, et al.
British Journal of Haematology
|
January 17, 2007
Adoptive transfer of syngeneic T cells in HIV-1 discordant twins indicates rapid regulation of T-cell homeostasis
Christian Hoffmann, Hans-Juergen Stellbrink, Thomas Dielschneider, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
February 16, 2021
Glecaprevir/pibrentasvir is safe and effective in hepatitis C patients with cirrhosis: Real-world data from the German Hepatitis C-Registry
Heiner Wedemeyer, Peter Erren, Uwe Naumann, et al.
Zeitschrift Fur Gastroenterologie
|
April 22, 2026
[Hyperlipasemia following therapy with direct antiviral drugs in patients with chronic hepatitis C virus infection - data from the German Hepatitis C Registry (DHC-R)]
Bernd Heinrich, Peter Buggisch, Gerlinde Teuber, et al.
Deutsches Arzteblatt International
|
March 16, 2011
HIV and cancer in Germany
Manfred Hensel, Armin Goetzenich, Thomas Lutz, et al.
AIDS Care
|
February 29, 2020
Physical and mental health in HIV-infected patients with virological success and long-term exposure to antiretroviral therapy
Michael Sabranski, Gesa Erdbeer, Ina Sonntag, et al.
Zeitschrift Fur Gastroenterologie
|
July 15, 2022
Real-world experience for the outcomes and costs of treating hepatitis C patients: Results from the German Hepatitis C-Registry (DHC-R)
Kathrin Krüger, Siegbert Rossol, Christian Krauth, et al.
Journal of Viral Hepatitis
|
August 2, 2021
The changing characteristics of patients infected with chronic hepatitis C virus from 2014 to 2019: Real-world data from the German Hepatitis C-Registry (DHC-R)
Dietrich Hüppe, Albrecht Stoehr, Peter Buggisch, et al.
Plos One
|
June 16, 2022
Prognostic impact of steatosis in the clinical course of chronic HCV infection-Results from the German Hepatitis C-Registry
Monika Rau, Peter Buggisch, Stefan Mauss, et al.
Viruses
|
July 27, 2022
Real-World Safety, Effectiveness, and Patient-Reported Outcomes in Patients with Chronic Hepatitis C Virus Infection Treated with Glecaprevir/Pibrentasvir: Updated Data from the German Hepatitis C-Registry (DHC-R)
Markus Cornberg, Albrecht Stoehr, Uwe Naumann, et al.
Page
of 6